Covid Diabetes, Colliding in a Public Health Train Wreck

Diabetes is an insidious disease that significantly increases the risks of premature blindness, stroke, circulatory neurological problems that can lead to infections requiring amputation of gangrenous toes feet.As with many chronic conditions, the poor people of color are diagnosed with diabetes at disproportionately higher rates. Black Latino Americans are more than twice as likely to receive a diabetes diagnosis as whites, inadequate access to medical care can make it harder for them to juggle the complex dietary, monitoring treatment regimens that can stave off its devastating complications.Although there is much researchers don’t understand, many believe that uncontrolled diabetes greatly amplifies the perils of a Covid diagnosis. That’s because a sedentary lifestyle, putting on extra weight or failing to keep close tabs on blood sugar levels fuel chronic inflammation inside the body, which can increase insulin resistance weaken the immune system.

Inflammation triggers the release of cytokines, tiny proteins that regulate the body’s immune response to infection or injury. Cytokines are a critical component of the normal healing process, but for people with diabetes underlying chronic inflammation, all those cytokines can damage healthy tissue. Covid, it turns out, can provoke an uncontrolled release of cytokines, the resulting “cytokine storm” can wreak havoc on vital organs like the lungs, leading to dire outcomes death.

People with type 2 diabetes tend to fare more poorly than those with type 1, in part because those with type 1 tend to be younger.

In some respects, the pandemic has already had some positive effects on diabetes care by elevating the adoption of technology that enables remote management of the disease. The ramped up embrace of telemedicine, for example, has made it possible for health care providers to spot a worrisome foot wound on a homebound patient.

Early in the pandemic, the Food Drug Administration gave hospitals long-term care facilities permission to distribute continuous glucose monitoring devices to coronavirus patients as a way of reducing the risks to health care workers. Clinicians have also learned the nuances of caring for hospitalized diabetics with Covid through more intensive monitoring management of blood sugar levels.

But many advancements have been unevenly distributed. The uninsured cannot afford the latest glucose monitoring or insulin delivery devices, in economically disadvantaged communities with low digital literacy, experts say that doctors are less likely to offer new technologies treatments to Black Hispanic patients, even when they are covered by insurance.

“The advances of recent years have been stunning but not everyone has access to them that’s just tragic,” said Dr. Ruth S. Weinstock, a board member of the American Diabetes Association.

Source link